97 related articles for article (PubMed ID: 23480724)
1. DNA-loaded chitosan oligosaccharide nanoparticles with enhanced permeability across Calu-3 cells.
Ye Y; Xu Y; Liang W; Leung GP; Cheung KH; Zheng C; Chen F; Lam JK
J Drug Target; 2013 May; 21(5):474-86. PubMed ID: 23480724
[TBL] [Abstract][Full Text] [Related]
2. Development and characterization of a new plasmid delivery system based on chitosan-sodium deoxycholate nanoparticles.
Cadete A; Figueiredo L; Lopes R; Calado CC; Almeida AJ; Gonçalves LM
Eur J Pharm Sci; 2012 Mar; 45(4):451-8. PubMed ID: 21986445
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system.
Amidi M; Romeijn SG; Borchard G; Junginger HE; Hennink WE; Jiskoot W
J Control Release; 2006 Mar; 111(1-2):107-16. PubMed ID: 16380189
[TBL] [Abstract][Full Text] [Related]
4. Permeation enhancer effect of chitosan and chitosan derivatives: comparison of formulations as soluble polymers and nanoparticulate systems on insulin absorption in Caco-2 cells.
Sadeghi AM; Dorkoosh FA; Avadi MR; Weinhold M; Bayat A; Delie F; Gurny R; Larijani B; Rafiee-Tehrani M; Junginger HE
Eur J Pharm Biopharm; 2008 Sep; 70(1):270-8. PubMed ID: 18492606
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of neuropeptide loaded trimethyl chitosan nanoparticles for nose to brain delivery.
Kumar M; Pandey RS; Patra KC; Jain SK; Soni ML; Dangi JS; Madan J
Int J Biol Macromol; 2013 Oct; 61():189-95. PubMed ID: 23831532
[TBL] [Abstract][Full Text] [Related]
6. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique.
Fan W; Yan W; Xu Z; Ni H
Colloids Surf B Biointerfaces; 2012 Feb; 90():21-7. PubMed ID: 22014934
[TBL] [Abstract][Full Text] [Related]
7. Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery.
Plapied L; Vandermeulen G; Vroman B; Préat V; des Rieux A
Int J Pharm; 2010 Oct; 398(1-2):210-8. PubMed ID: 20674728
[TBL] [Abstract][Full Text] [Related]
8. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
9. Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles.
Zhang X; Zhang H; Wu Z; Wang Z; Niu H; Li C
Eur J Pharm Biopharm; 2008 Mar; 68(3):526-34. PubMed ID: 17881202
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of cyclobenzaprine hydrochloride-loaded thiolated chitosan nanoparticles for pain relief.
Patel D; Naik S; Chuttani K; Mathur R; Mishra AK; Misra A
J Drug Target; 2013 Sep; 21(8):759-69. PubMed ID: 23879335
[TBL] [Abstract][Full Text] [Related]
11. Tight junction modulation by chitosan nanoparticles: comparison with chitosan solution.
Vllasaliu D; Exposito-Harris R; Heras A; Casettari L; Garnett M; Illum L; Stolnik S
Int J Pharm; 2010 Nov; 400(1-2):183-93. PubMed ID: 20727955
[TBL] [Abstract][Full Text] [Related]
12. Chitosan/cyclodextrin nanoparticles can efficiently transfect the airway epithelium in vitro.
Teijeiro-Osorio D; Remuñán-López C; Alonso MJ
Eur J Pharm Biopharm; 2009 Feb; 71(2):257-63. PubMed ID: 18955137
[TBL] [Abstract][Full Text] [Related]
13. Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.
Lin YH; Chung CK; Chen CT; Liang HF; Chen SC; Sung HW
Biomacromolecules; 2005; 6(2):1104-12. PubMed ID: 15762683
[TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of chitosan/β-cyclodextrin nanoparticles containing plasmid DNA encoding interleukin-12.
Nahaei M; Valizadeh H; Baradaran B; Nahaei MR; Asgari D; Hallaj-Nezhadi S; Dastmalchi S; Lotfipour F
Drug Res (Stuttg); 2013 Jan; 63(1):7-12. PubMed ID: 23447042
[TBL] [Abstract][Full Text] [Related]
15. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
[TBL] [Abstract][Full Text] [Related]
16. Preparation and evaluation of chitosan-DNA-FAP-B nanoparticles as a novel non-viral vector for gene delivery to the lung epithelial cells.
Mohammadi Z; Abolhassani M; Dorkoosh FA; Hosseinkhani S; Gilani K; Amini T; Najafabadi AR; Tehrani MR
Int J Pharm; 2011 May; 409(1-2):307-13. PubMed ID: 21356293
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary delivery of elcatonin using surface-modified liposomes to improve systemic absorption: polyvinyl alcohol with a hydrophobic anchor and chitosan oligosaccharide as effective surface modifiers.
Murata M; Nakano K; Tahara K; Tozuka Y; Takeuchi H
Eur J Pharm Biopharm; 2012 Feb; 80(2):340-6. PubMed ID: 22036988
[TBL] [Abstract][Full Text] [Related]
18. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
19. In vivo transfection study of chitosan-DNA-FAP-B nanoparticles as a new non viral vector for gene delivery to the lung.
Mohammadi Z; Dorkoosh FA; Hosseinkhani S; Gilani K; Amini T; Najafabadi AR; Tehrani MR
Int J Pharm; 2011 Dec; 421(1):183-8. PubMed ID: 21979252
[TBL] [Abstract][Full Text] [Related]
20. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
